We are live on
!
Find out more
CASI
CASI Pharmaceuticals
CASI
CASI
Delisted
CASI was delisted on the 25th of February, 2026.
27 hedge funds and large institutions have $5.8M invested in CASI Pharmaceuticals in 2013 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 7 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
4% more funds holding
Funds holding: 26 → 27 (+1)
4% more capital invested
Capital invested by funds: $5.56M → $5.8M (+$241K)
14% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 7
Holders
27
Holders Change
+1
Holders Change %
+3.85%
% of All Funds
0.88%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
6
Reduced
7
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
CNB
City National Bank
Beverly Hills,
California
|
+$33K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$12.7K |
| 3 |
SM
Sabby Management
Miami Beach,
Florida
|
+$12.1K |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$4.1K |
| 5 |
U
UBS
Zurich,
Switzerland
|
+$3.84K |
Top Sellers
| 1 |
WJA
Williams Jones & Associates
New York
|
-$43K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$27K |
| 3 |
EEG
E.E. Geduld
|
-$9.5K |
| 4 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
-$1.48K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$1.29K |
